D R Burton Healthcare Products LLC Introduces OPEP Products at The American Association of Respiratory Care Congress, October 15-18, 2016, Booth 101

Share Article

The D R Burton Family of OPEP therapy devices includes the iPEP® - the only volumetric-based OPEP therapy

News Image

D R Burton family of OPEP Products

The iPEP® takes the mystery out of OPEP therapy by providing patients and healthcare providers with important and immediate feedback that measures the patient’s inspiratory capacity during therapy.

D R Burton Healthcare Products LLC, makers of respiratory products and other medical devices, introduces oscillating positive expiratory pressure (OPEP) products at the American Association of Respiratory Care Congress (AARC) in San Antonio, TX on October 15-18, 2016 in booths 101 and 103.

D R Burton is the first company to bring innovative, new technology to OPEP therapy in recent years. "The iPEP system represents a breakthrough in airway secretion clearance therapy by providing patented volumetric-based OPEP therapy. Treating atelectatsis starts with lung volume. The iPEP takes the mystery out of OPEP therapy by providing patients and healthcare providers with important and immediate feedback in real time that measures the patient’s inspiratory capacity during therapy,” according to Dennis Cook, BSRT, RRT, CEO of D R Burton.

There is a need to prevent pneumonia in high risk patients, such as postoperative and patients with increased mucous production. Cook explains, “The D R Burton family of OPEP products are designed to reduce the risk of not only hospital acquired pneumonia, but also reduce risk of pneumonia post discharge." The iPEP system includes a palm-sized PocketPEP®, a compact OPEP device for active patients for use at home to help prevent pulmonary-related readmissions.

The D R Burton family of patented innovative OPEP products includes the vPEP® system which provides superior performance even for patients with low breath volume. “The vPEP features adjustable resistance with superior amplitude and consistent frequency even for low volume patients, such as COPD, Cystic Fibrosis, and pediatric patient populations,” says Cook. “The vPEP is also the easiest OPEP for patients with only four parts to assemble and clean, helping to reduce risk of infection,” he adds.

"Our objective at D R Burton is to make it easier for clinicians to deliver care with simple products that are easier for patients both at-home and in the hospital." According to Cook, “It’s our mission at D R Burton to win the war on healthcare acquired pneumonia and respiratory-related readmissions.”

Cook and the D R Burton co-founders, Dr. Joyce Burton and Dr. Chester Burton, will be meeting with clinicians to discuss these products and other innovative concepts at the AARC Congress, 101 & 103, on October 15-18, 2016.

About D R Burton Healthcare Products LLC
D R Burton Healthcare Products LLC, innovators in medical devices, was founded by physicians and healthcare clinicians with deep expertise in respiratory care. Together we design, develop and market medical device products that allow patients to heal faster and provide value to our partners and consumers. Our unique clinical perspective drives our unwavering commitment to provide clinicians and their patients with a world class user experience. For more information, please visit http://www.drburtonhpi.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Debra Kurtz
Visit website

Media